This message was sent to ##Email##
|
| February 13, 2019 |
| |  | | |
|
|
|
| |
Cancer Network
HPV testing performed on cervicovaginal samples self-collected by patients had a similar accuracy for identifying cervical intraepithelial neoplasia as samples collected by clinicians, according to the results of a recent study. "These findings suggest that HPV self-sampling — with a suitable combination of self-sampling device and PCR-based HPV assay — could be used as a primary screening method in nationwide screening programmes," wrote researcher Nicole J. Polman, MD, of Cancer Centre Amsterdam, and colleagues. "Wider use of HPV self-sampling could greatly reduce the workload of clinicians doing cervical sampling, reducing the costs of screening, and lowering barriers to screening in countries with low or moderate screening coverage."
READ MORE
ASCT
We are happy to announce that the ASCT Foundation will once again hold a silent auction during this year’s ASCT Annual Conference! Monies raised will go directly toward helping the ASCT Foundation fulfill its mission to support and enhance many of the programs provided by ASCT. In addition to educational programs and awards, the Foundation supports student attendance at the ASCT Annual Conference by covering the registration fee for student members who register by the early deadline. In addition, the Foundation recently introduced Rookie of the Year Award, a scholarship that will cover the cost of travel and registration for a recent graduate.
The foundation is currently seeking donations of items for the auction. Previous donations have included original artwork, hand-made craft items, gift cards, and cytology text books. If you would like to donate contact Jodie Woodside at Jodie.woodside@gmail.com.
 |
|
EcoVue® was designed with patient safety in mind, our non-refillable and single use products will forever CHANGE YOUR VUE of ultrasound gel.
www.EcoVue.com
|
|
| Date |
Event |
Location |
More information |
February, 20 2019 |
Communication in the Work Place
|
your PC |
Guliz A. Barkan, MD
Department of Pathology
Loyola University Medical Center - Chicago
Details
|
March, 27 2019 |
Cytopreparation: What techniques are best for cytologic samples?
|
your PC |
Kelsey Snyder, MS, CT(ASCP)
Details
|
April, 17 2019 |
Head and Neck Cytopathology
|
your PC |
Abbey Lott Limbach, MD
Department of Pathology
The Ohio State University Medical Center
Details
|
June 2019 |
The Engagement of Cytotechnologists in Genomic Selections Leads to
Improved Outcomes
|
your PC |
Melissa Randolph, BS, SCT(ASCP)
Details
|
July, 17 2019 |
TBA
|
your PC |
Eva Wojcik, MD
Department of Pathology
Loyola University Medical Center - Chicago
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
Cancer Therapy Advisor
Study researchers have identified a human papillomavirus gene signature associated with outcomes among patients with HPV-related oropharyngeal cancers. Using a panel of 582 genes, three subgroups were identified: HPV-negative tumors and two different HPV-positive tumor subgroups. One HPV-positive subgroup had similar survival to that of HPV-negative tumors and suggested a distinctly different subgroup within HPV-positive tumors. Statistically significant differences in survival were found among all three groups. Further investigation revealed a 38-gene panel that could differentiate between the two HPV-positive tumor groups and was associated with a difference in survival.
READ MORE
Medical Xpress
To mark World Cancer Day 2019, the International Agency for Research on Cancer issued a statement in which it "unequivocally confirms the efficacy and safety of HPV vaccination." "Unfounded rumours about HPV vaccines continue to unnecessarily delay or impede the scaling up of the vaccination, which is so urgently needed to prevent cervical cancer," said IARC director Elisabete Weiderpass. More than half a million new cervical cancers were diagnosed in the world in 2018, said the IARC.
READ MORE
The Philadelphia Inquirer
A study released online found the HPV vaccine reduced strains of the virus and prevented its spread over a 10 year period. Young women 13 to 26 years of age were recruited from hospital-based and community health clinics for four studies — 1,580 participants in total — from 2006 to 2017. The promising results indicated that since the introduction of the HPV 4-valent and HPV 9-valent vaccines (4-types and 9-types of HPV, respectively), there has been a significant decrease in the various covered strains infection rates. Also, prevalence of these same types of HPV have also decreased in women who were not vaccinated. More specifically, the HPV-4 vaccine showed a decrease of 80 percent in various strains for the vaccinated, and prevalence of these same types of HPV also decreased by 40 percent in women who were not vaccinated — implying a herd immunity.
READ MORE
Cancer Network
Curtis Pickering, Ph.D., is assistant professor of head and neck cancer at the University of Texas MD Anderson Cancer Center in Houston. He coauthored a new study describing candidate prognostic gene expression signatures for human papillomavirus-positive oropharyngeal and cervical cancers. The team's goal was to validate a gene panel that can identify lower-risk patients for whom treatment can be safely de-escalated, reducing potential treatment toxicities. Pickering answered a few questions for Cancer Network about the study's findings.
READ MORE
MDLinx
In a study on mouse models and human tissue, researchers have revealed how aggressive forms of skin cancer are able to co-opt the immune system to become invasive. Knowing this could lead to better, more effective treatments. New research has found a mechanism that allows aggressive forms of skin cancer to become invasive and spread quickly.
READ MORE
Futurity
Lung cancer is the most common cancer worldwide, with 1.3 million new diagnoses every year. It has one of the lowest survival outcomes of any cancer because more than two-thirds of patients receive a diagnosis too late for curative treatment.
READ MORE
UPI
Taking aspirin and ibuprofen regularly significantly improves survival rates for about 33 percent of patients with head and neck cancer, a study says. The 5-year survival rates of patients with cancer containing the PIK3CA gene shot up from 25 percent to 78 percent among those using the drugs, according to a study published in the Journal of Experimental Medicine. "Our results suggest that the use of NSAIDs could significantly improve outcomes for not only head and neck cancer patients, but also patients with other cancers that contained the PIK3CA mutation," Jennifer R. Grandis, a professor of head and neck surgery at University of California at San Francisco and study senior author, said in a press release.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
